'Molecular tests' presentation slideshows

The expanding threat of antibiotic resistance and the antimicrobial stewardship response

The expanding threat of antibiotic resistance and the antimicrobial stewardship response. Donald Chen MD Associate Hospital Epidemiologist, NYULMC Assistant Professor of Medicine and Microbiology NYU School of Medicine March 19, 2014. Antibiotic resistance.

966 views • 71 slides

Microbiological diagnosis of TB

1.37k views • 56 slides

Laboratory Diagnostics: from Eminence based to Evidence based

Laboratory Diagnostics: from Eminence based to Evidence based. G. Ieven 28/09/04. Evidence Based Diagnostic Microbiology. = Part of Evidence based Medicine

559 views • 55 slides

Molecular Diagnostic Lab Pre-analytic Improvements (Phase II Project)

Molecular Diagnostic Lab Pre-analytic Improvements (Phase II Project). Dr. Lavinia P. Middleton, MD Ron A. Phipps, MBA. Background. In the treatment of cancer: Personalized medicine is the use of genetic markers and/or pharmacogenomic testing to tailor an individual's therapy.

414 views • 28 slides

Genetics and Pathology

Genetics and Pathology. What can they do for each other?. Scottish Association of Histotechnology; Friday 27 th May 2011. National Initiatives Affecting Both Disciplines. Scottish Genetic Laboratory Consortium. Nationally funded NHS Genetic Services

380 views • 23 slides

Overview of Newborn Screening Molecular Assays

Overview of Newborn Screening Molecular Assays. Susan M Tanksley, PhD June 28, 2011. Outline. Introduction to molecular testing for genetic diseases Brief history of molecular testing in NBS When & why to use a molecular test Availability of NBS molecular tests in different states

399 views • 22 slides

Molecular diagnosis of UPT: when?

UPT 3-5% of all tumors at presentation. 15% remain undiagnosed (estimated to be 4000 per year in the USA). Of which about 85% diagnosed by clinical history, physical examination, conventional lab tests, radiologic imaging, morphology, routine immunohistochemistry). Molecular diagnosis

346 views • 22 slides

ITMO Cancer

ITMO Cancer. From Precision to Personalised Medicine Brussels 24/09/2013. CEA. CHRU. CNRS. CPU. INRA. INRIA. INSERM. INSTITUT PASTEUR. IRD. ARIIS. CIRAD. EFS. FONDATION MERIEUX. INERIS. INSTITUT CURIE. INSTITUT MINES-TELECOM. IRBA. IRSN. UNICANCER.

347 views • 19 slides

Clinical Performance of the APTIMA HPV Assay for Detection of E6/E7 mRNA from High-Risk HPV Types in Liquid Based Cytolo

Persistent HPV Infection. Initial HPV Infection. Host Chromosomal DNA. Episomal HPV DNA. HPV DNA Integration. E6/7 RNA. Low level E6/E7 mRNA expression Low probability of progression to disease. Increased E6/E7 mRNA expression Increased probability of progression to disease. E6/7 RNA.

514 views • 1 slides